Nerve-stimulation or the imposition of intermittent changes in tension (MS) on both isolated rat diaphragm (Reeds t't a/., 1980) and isolated rabbit forelimb digit extensor muscles (Palmer c t d . , 1 9 8 1~) and myotubes in culture (Vandenburgh & Kaufman, 1979) significantly increase the synthesis of total. myofibrillar and collagenous proteins. In skeletal muscle the stimulation of protein synthesis by MS was insensitive to a variety of neurotoxins (Palmer et al., 1981h; Smith ct al., 1983) but the presence of the nonsteroidal anti-inflammatory drugs, indomethacin and meclofenamic acid. blocked the effect of M S on protein synthesis (Smith et al., 1983) . These drugs inhibit the enzyme cyclo-oxygenase (Flower, 1974) and under some circumstances indomethacin also inhibits phospholipase A? (Franson rt al., 1980) . resulting in an inhibition of the synthesis of the prostaglandins, thromboxanes and prostacyclins. The fact that they inhibited the stimulated (but not the basal) rate of protein synthesis suggested an involvement of arachidonic acid metabolism via the cyclo-oxygenase pathway in the stimulation of protein synthesis.
Later work showed that both drugs also blocked the acute effect of insulin on muscle protein synthesis in vitro and in vivo (Reeds et ul., 1985) without inhibiting the specific binding of physiological levels of the hormone, at least in vitro . The addition of arachidonic acid (10 '-10 'M) in vitro also stimulated protein synthesis in isolated rabbit muscles by a mechanism that was sensitive to indomethacin and meclofenamate. Palmer & Wahle (1987) have shown that this effect of arachidonic acid is shared by at least one other n ~ 6-unsaturated Abbreviations used: MS, nerve-stimulation or imposition of intermittent changes in tcnsion; PG. prostaglandin. fatty acid (dihomo-;.-linolenic acid) but not by n ~ 3-unsaturated fatty acids. Finally, the ?-series prostaglandin. PGF,, (2 x 1 0~-'~) , was shown to stimulate protein synthesis in isolated rat soleus and in isolated rabbit digit extensor muscles (Smith et a/., 1983) . and both MS and insulin increased the release of PGF2# by isolated muscles.
The glucocorticoid hormones have long been known t o lead to a loss of muscle protein (Goldberg, 1969) and it is generally agreed that both natural and synthetic glucocorticoids inhibit protein synthesis both in vivo (Odedra et (11.. 1983; Tomas et al., 1984) and in vitro (Rannels & Jefferson, 1980) . In addition, these steroids also have an antiinflammatory action resulting from an inhibition of prostaglandin, thromboxane and leukotriene synthesis (Kantrowitz et al., 1975; Hong & Levine, 1976; Blackwell et al., 1980) . This inhibition of eicosanoid synthesis is achieved by a stimulation of the synthesis or the release of a family of phospholipase A? inhibitory proteins variously termed macrocortin, lipocortin, lipomodulin or renocortin (Blackwell et al., 1980; Hirata et a/., 1980; Rothut ct ul., 1983) .
In general, we have f:und that extreme conditions, such as gross depletion of Ca-' (Palmer ct al., 1983; Smith i ' / ul., 1983) , are necessary to bring about an inhibition of both the basal release of prostaglandins and basal protein synthesis in isolated rabbit muscles, and in our hands the non-steroidal anti-inflammatory drugs that we had used were largely ineffective in this respect. In contrast, in skeletal muscles from fed animals the synthetic glucocorticoid dexamethasone (10 'M) inhibited basal protein synthesis in vitro by about 30% (McGrath & Goldspink, 1982; Reeds & Palmer, 1984) but did so only after a time lag of 2.5-3.5 h. The time course of the steroid-induced inhibition of protein synthesis coincided with that of an inhibition of prostaglandin release (Reeds & Palmer, 1984) . Taken together the results suggested that factors external to the muscle might alter protein synthesis by interactions with membrane arachidonic acid metabolism. Furthermore, although they might act primarily by altering the activity of phospholipase A? (although other pathways are possible; see , the final effect appears to be mediated by a cyclo-oxygenase product, probably PGF?,,.
The mechanism of the effects of these various stimuli on arachidonate metabolism is unknown. This is a critical question as other products of phospholipid metabolism have been closely associated with the modulation of cellular metabolism. I t seems possible to us that the hormones on one hand and MS on the other may affect arachidonate production by different mechanisms. M S may induce a transient alteration in the structural relationships between the phospholipase A? and the phospholipid substrates (such as phosphatidylethanolamine; Craven & De Rubertis, 1983) , while glucocorticoids, and possibly insulin, may influence the activity of an endogeneous phospholipase inhibitor. Two observations support this possibility. First, MS and insulin have an additive effect on both protein synthesis and prostaglandin release. Secondly, although dexamethasone reduces the rate of protein synthesis in muscles subjected to MS (Reeds & Palmer, 1984) . the stimulation by MS above the inhibited basal rate is still evident. On the other hand. in the presence of dexamethasone the effect of insulin on protein synthesis is blunted (Table I) .
Recent work has shown that in vitro the presence of dexamethasone stimulates the release or production of a phospholipase A? inhibitor by isolated rabbit muscles (R. M . Palmer work), an effect reminiscent of the effect of the steroid in other cells (see above). It is particularly interesting that the activity of lipocortin is inhibited by phosphorylation (Hirata, 1981) and this protein has been shown recently to be a 'physiological' substrate for the epidermal growth factor receptor tyrosine kinase (Pepinsky & Sinclair, 1986) . It is possible therefore that insulin stimulates prostaglandin production in muscle by altering the phosphorylation state of a protein analogous in action to lipocortin and thus relieves a pre-existing inhibition of phospholipase A,.
Prostaglandins and the control of protein degradation in skeketul muscke Possible involvement in pathological changes in muscle protein metabolism. In principle, protein degradation is as important as protein synthesis in the control of cellular protein mass. One feature of the physiological control of growth in muscle is a co-ordinated stimulation of both processes. termed 'anabolic catabolism' by Millward & Waterlow (1978) . This general observation can be reproduced to some extent in vitro (see for example Palmer et al., 1985) . The co-ordination of response suggests that both processes may be controlled by closely related factors. suggested that the control of the relative rates of synthesis or degradation of PGFzl and PGE, could be important elements in the 'fine tuning' of the relative rates of protein synthesis and degradation.
In mild trauma and infection protein synthesis and degradation in the whole body (Clague et al., 1983 ; Tomkins P I ul.. 1983) and muscle (Tischler & Fagan, 1983 ) are both increased, despite the net loss of protein from the body. However, under extreme conditions of muscle protein loss, such as terminal starvation (Millward & Waterlow, 19781 , diabetes (Pain et al., 1983) , severe trauma and infection (Clowes et al., 1983; Yang et al., 1983; Clark et al., 1984) and Escherichia coli endotoxin shock, this co-ordination is lost and protein synthesis is either unaltered (Clark et al., 1984) or reduced in the face of an increase in protein degradation (Clowes et al., 1983; Turinsky & Loergering, 1985; Jepson et al., 1986) . Burn injury (Clark et al., 1984) , sepsis (Turinsky & Loegering, 1985) or treatment of animals with E. coli endotoxin (Fagan & Goldberg, 1985) are all associated with extremely high levels of prostaglandin production, reflecting a high rate of phospholipolysis. The critical question is whether the changes in protein turnover are a reflection of the membrane disruption consequent on the loss of membrane phospholipids or whether the arachidonate metabolites so produced play a specific role.
In favour of the former is the protective effect exerted by exogenous phospholipids in endotoxin shock (Liu et a/., 1983) . On the other hand, fever and acute-phase protein synthesis in the liver appear to be caused by the production of a series of polypeptides by activated lymphocytes and may involve PGE, (Dinarello & Wolff, 1982) . Interestingly, Baracos et (11. (1983) showed that in vitro the lymphokine interleukin 1 stimulated muscle protein degradation (but not protein synthesis) in association with a very marked increase in prostaglandin release. The protein degradative effect of interleukin I was blocked by indomethacin, echoing earlier demonstrations of the effects of the drug on the acute-phase response (Rowe et al., 1979) . Subsequently, both Ruff & Secrist (1984) using rats infected with live Streptococcus pneumoniae, as well as Wan & Grimble (1986) using E. coli endotoxin-treated rats, showed that indomethacin treatment before and during the insult blocked the loss of muscle protein. Despite these observations the changes in protein synthesis and degradation that occur under pathological conditions do not simply fit the idea that the co-ordinated stimulation of protein synthesis and degradation relates to the co-ordinated activation of PGF,, and PGE, production.
However, when we studied the effects of high concentrations of exogenous arachidonate on protein turnover the response proved to be complex ( Table 2 ). The maximum Vol. 15 stimulation of protein synthesis occurred at arachidonate concentrations of between 0.1 and 1 PM and protein synthesis showed no further response between 1 and 1 0 0~~. Above 100 PM, however, protein synthesis was progressively decreased. This secondary inhibition might be caused by the appearance of products of the lipoxygenase pathway as there is evidence that enzyme leakage from Ca2+ ionophore treated muscles are blocked by lipoxygenase inhibitors (Jackson et al., 1987 ). An alternative explanation may be that toxic auto-oxidation products of arachidonate are formed when high levels of the free acid are present.
In contrast to the biphasic response of protein synthesis, protein degradation responded poorly to arachidonate concentrations below 5 pM-arachidonate but at higher concentrations it showed a linear doseeresponse. It is possible then that the nature of the relative changes in protein synthesis and degradation under various pathological conditions may be a reflection of the degree to which muscle membrane phospholipolysis is stimulated.
Comments on the link between arachidonic acid metabolism unciprotein synthesis. Although the above evidence suggests a causal link between arachidonic acid release and metabolism and protein turnover in muscle, the nature of this link remains a mystery. It may well be indirect, despite the observations that additions of prostaglandins themselves will stimulate protein synthesis in skeletal muscle and in other cells (Jimenz de Ausa et al., 1977) . A further and important point has emerged from recent work. In contrast to the observations of Ruff & Secrist (1984) and Wan & Grimble (1 986), both Clark et al.
( 1 984) and Turinsky & Loegering ( 1985) found that although indomethacin added to isolated muscles removed from burnt or infected animals greatly reduced the elevated rate of PGE, production, the rate of protein degradation was little altered. A similar observation with regard to the action of insulin on protein synthesis in vitro has been obtained (Palmer et ul., 1986 ) and the results obtained by Fagan & Goldberg (1985) are compatible with our results. Furthermore, in vivo, insulinstimulated protein synthesis becomes progressively insensitive to indomethacin the longer insulin is allowed to act before the injection of the inhibitor (P. J. Garlick, I. Grant, S . M . Hay & P. J . Reeds, unpublished work) . It appears then that arachidonic acid metabolism is closely involved in the initiation of the changes in protein turnover but not in their maintenance.
I t seems most likely to us that the initial stimulation of arachidonic acid metabolism induced by a primary stimulus to phospholipase Az sets in train a further series of events in the plasma membrane. These secondary responses may involve other pathways of phospholipid breakdown, especially those linked via phospholipase C which is known to be sensitive to PGF,, (Siess et al., 1983) . If this is so, then the acute effects of insulin may involve the activation of protein kinase C and we have shown that low ( 1 0 -9~) levels of phorbol 12-myristate 13-acetate stimulate muscle protein synthesis by a partially indomethacin-insensitive step ( K . W. J. Wahle, R. M . Palmer, & P. J. Reeds, unpublished work) and J. E. Hesketh (personal communication) has found that depletion of protein kinase C will inhibit the ability of insulin to acutely stimulate protein synthesis in BT3-fibroblasts. The next stage of the link may then be a stimulation of S6 kinase (Perisic & Traugh, 1983) , although this is a controversial topic.
Whatever the mechansim ultimately proves to be it appears that the induction by extracellular factors of changes in protein turnover in skeletal muscle may be linked by closely related control pathways. Perhaps the pathological changes in muscle protein turnover may be due to the uncontrolled stimulation of the physiological control mechanisms rather than to the induction of additional specific processes of control.
Fatty acids form the major fuels for energy production of working heart and of skeletal muscle at rest and during moderate and prolonged exercise. Only a small proportion of fatty acids taken up by muscle is used for anabolic processes such as triacylglycerol and phospholipid synthesis, in contrast to adipose tissue and liver. Blood-borne fatty acids are delivered to muscle bound to albumin or from triacylglycerols in chylomicrons and very-low-density lipoproteins after hydrolysis by lipoprotein lipase. The fatty acids are very effectively extracted by the heart from blood, 40-60% during one transmit time (Opie et al., 1973) , although they have to pass many barriers and compartments to reach the myocyte mitochondrion, where their main utilization (oxidation) takes place (Fig. I) . Endothelial cells lining the intravascular space have to extract and transfer the fatty acids to the interstitial space. Some fatty acids may also enter together with albumin through the endothelial clefts or through an intra-endothelial channel system of fused vesicles (Sejrsen et a/., 1985) . Albumin is present in the extracellular fluid (Yokota, 1982; Reed, 1985) and is probably involved in fatty acid binding and transport in this space (Julien et a/., 1978) . The higher transcapillary extravasation rate of albumin during activity of rat muscle (Reed, 1985) may be important in this respect.
The mechanism of the fatty acid transport from capillary to myocyte is still unclear. Wetzel & Scow (1984) proposed, on the basis of electron microscopic studies, that fatty acids would be transported by lateral movement in cell membranes in a continuum across the capillary endothelium and within myocytes, but there is no evidence for complete continuity, e.g. between the external leaflets of the plasma membranes of endothelial cells and myocytes.
The rate of fatty acid uptake by the peripheral tissues will depend on the concentration of the fatty acids in the blood, their intracellular concentration and their rate of utilization. The fatty acid/albumin ratio determines the concentration of unbound fatty acid (Spector et al., 1971; Wosilait & Soler-Argilaga, 1977 ). An increase in this ratio increases the uptake of fatty acid by the perfused rat heart (Evans et a/., VOl. 15
